Companies / Tenaya Therapeutics, Inc. / Activity
Activity — Tenaya Therapeutics, Inc.
28 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $1.46M | -2.2M -44.79% | 2,651,817 1.18% of shares | medium |
| Feb 11, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $1.30M | -1.9M -44.79% | 2,348,183 1.05% of shares | medium |
| Feb 25, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $1.05M | -1.9M -100.00% | 0 0.00% of shares | medium |
| Feb 25, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $927.6K | -1.6M -100.00% | 0 0.00% of shares | medium |
| Feb 24, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $214.9K | -349K -15.79% | 1,862,545 0.83% of shares | medium |
| Feb 24, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $190.3K | -309K -15.79% | 1,649,281 0.74% of shares | medium |
| Feb 20, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $170.8K | -278K -10.47% | 2,374,048 1.06% of shares | medium |
| Feb 20, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $151.2K | -246K -10.47% | 2,102,218 0.94% of shares | medium |
| Feb 10, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $148.8K | -182K -3.66% | 4,803,275 2.14% of shares | medium |
| Feb 10, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $131.7K | -161K -3.66% | 4,253,298 1.90% of shares | medium |
| Feb 23, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $96.9K | -162K -6.84% | 2,211,757 0.99% of shares | low |
| Feb 23, 2026 | The Column Group III GP, LP 10% owner | Sell | Common Stock | $85.8K | -144K -6.84% | 1,958,509 0.87% of shares | low |
| Feb 17, 2026 | Ali Faraz CEO | Sell | Common Stock | $3.8K | -6K -1.28% | 452,415 0.20% of shares | low |
| Feb 17, 2026 | Ali Faraz CEO | Sell | Common Stock | $3.2K | -5K -1.12% | 443,404 0.20% of shares | low |
| Feb 17, 2026 | Ali Faraz CEO | Sell | Common Stock | $2.6K | -4K -0.88% | 448,436 0.20% of shares | low |
| Feb 17, 2026 | Higa Tomohiro Executive | Sell | Common Stock | $1.3K | -2K -1.66% | 119,752 0.05% of shares | low |
| Feb 17, 2026 | Tingley Whittemore Executive | Sell | Common Stock | $1.2K | -2K -0.85% | 218,618 0.10% of shares | low |
| Feb 17, 2026 | Tingley Whittemore Executive | Sell | Common Stock | $1.1K | -2K -0.74% | 220,494 0.10% of shares | low |
| Feb 17, 2026 | Tingley Whittemore Executive | Sell | Common Stock | $1.1K | -2K -0.73% | 222,136 0.10% of shares | low |
| Feb 17, 2026 | Higa Tomohiro Executive | Sell | Common Stock | $538 | -836 -0.68% | 121,774 0.05% of shares | low |
| Feb 17, 2026 | Higa Tomohiro Executive | Sell | Common Stock | $393 | -611 -0.50% | 122,610 0.05% of shares | low |
| Feb 3, 2026 | Higa Tomohiro Executive | Grant | Common Stock | $0 | +29K +31.13% | 123,221 0.05% of shares | low |
| Feb 3, 2026 | Tingley Whittemore Executive | Grant | Common Stock | $0 | +49K +27.85% | 223,778 0.10% of shares | low |
| Feb 3, 2026 | Ali Faraz CEO | Grant | Common Stock | $0 | +159K +52.93% | 458,266 0.20% of shares | low |
| May 28, 2026 | Williams R Sanders Director | Grant | Stock Option (Right to buy) | — | +120K | 120,000 0.05% of shares | low |
| Feb 3, 2026 | Higa Tomohiro Executive | Grant | Stock Option (Right to buy) | — | +176K | 175,500 0.08% of shares | low |
| Feb 3, 2026 | Tingley Whittemore Executive | Grant | Stock Option (Right to buy) | — | +319K | 318,500 0.14% of shares | low |
| Feb 3, 2026 | Ali Faraz CEO | Grant | Stock Option (Right to buy) | — | +952K | 952,250 0.42% of shares | low |